StockMarketWire.com - Hemogenyx Pharmaceuticals has entered into a collaboration with the University of Oxford to test new means of accelerating and improving the process by which transplanted blood stem cells grow and make healthy blood cells.


At 8:18am: [LON:HEMO] Hemogenyx Pharmaceuticals Plc Ord Gbp0.01 share price was +0.13p at 3.25p



Story provided by StockMarketWire.com